Research on Chemical and Biological Defense

 

To further the capability to prevent, detect, diagnose and treat the effects of chemical, radiological and biological warfare agents.

Active 12.360 Department of The Army, Department of Defense B - Project Grants Fiscal Year 2023 Health monitoring to improve diagnosis and treatment chronic pain in US service members, telehealth platform to deliver therapeutic care for US service members at high risk for post traumatic osteoarthritis, evaluation of a running sock designed to provide real time biofeedback to healthy US service members. 10 U.S.C. 4001 Applicants must be a public or private educational institution, a nonprofit organizations operated for purposes in the public interest, or a commercial firm. Beneficiaries are relatively independent investigators associated with an applicant organization. Applicants must furnish evidence of legal authorization, financial and managerial capability as well as a certification of compliance with Federal, State, and local environmental laws, ordinances and regulations. Applicants must be registered in System for Award Management (SAM). Also, the applicant, proposed subrecipients, and principals must not appear on the SAM Exclusions website as currently debarred, suspended, or otherwise ineligible. 2 CFR 200, Subpart E - Cost Principles applies to this program. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants should obtain a copy of the relevant BAA which describes the full research program areas of interest and includes necessary forms and instruction for preproposal/proposal submissions. The BAA is available for download, at no cost to the applicant, at www.fedbizopps.gov, www.jpeocbd.osd.mil, (search under ACC-APG-NCD), www.3.natick.army.mil/ and www.grants.gov. Award procedures are contained in the BAA and available for download at www.fedbizopps.gov (search under ACC-APG-NCD), www.jpeocbd.osd.mil, www.3.natick.army.mil/ and www.grants.gov describes the award procedures and criteria as well as the areas of interest and necessary forms and instructions for proposal submissions. Any relevant deadline(s) will be listed in the BAA or individual announcements. From 60 to 90 days. See the relevant BAA or individual announcement. Not applicable. Once a grant is awarded, any follow-on research proposal may be treated as a new request. Follow-on work should allow for review time noted above. As specified in the relevant BAA or individual announcement Recipients are required to conform to their accepted research protocol and are usually required to submit some form of performance report. Performance Reports: Performance monitoring is required as described in the individual announcement. In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Record keeping requirements are in accordance with the terms and conditions of the award, which will include appropriate provisions related to recipient records that are required by the DoDGARs. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. The length of time for which support is requested should be consistent with the nature and complexity of the proposed research. The maximum period acceptable for a research proposal is 5 years. Funds are normally released on a quarterly basis. None/Not specified. Richard W. Totten
110 Thomas Johnson Drive
Frederick, MD 21702 US
richard.w.totten2.civ@mail.mil
Phone: 3016192446

Scott Hoffman
110 Thomas Johnson Dr.
Frederick, MD 21702 USA
scott.i.hoffman2.civ@army.mil
Phone: 301-619-8482 http://wwwjpeocbd.osd.mil/ 97-0400-0-1-051 (Project Grants) FY 22$1,000,000.00; FY 23 est $100,000.00; FY 24 est $1,000,000.00; FY 21$1,000,000.00; FY 20$1,000,000.00; FY 19$843,414.00; FY 18$1,000,000.00; FY 17$0.00; FY 14$8,467,000.00; FY 16$0.00; FY 15$4,602,000.00; - $10,000 - $1,000,000 Department of Defense Grant and Agreement Regulations (DoDGARS) (as updated through DoD's interim implementation of 2 CFR part 200 which can be found at 2 CFR part 1103) and individual program announcements Fiscal Year 2023 Research related to medical/biological prophylaxis; prevention, treatment, or supportive care regimens for adverse reactions to prophylaxis or pretreatments against bio-warfare agents; Development of improved methods for delivery of vaccines, including adjuvants, nucleic acid vaccines, methods for oral or nasal immunization with inactivated, live and subunit antigens; sustained release formulations; and methods for delivery of antigens for specific induction of mucosal immunity and development of methods to enhance appropriate immune responses to include co- delivery of cytokines; prophylactic/pretreatment and therapeutic pharmaceuticals are non-vaccine pharmacological or biological products used to prevent or treat patients exposed to either chemical warfare agents (CWA) or biological warfare agents (BWA); Prophylactic/pretreatment and therapeutic pharmaceuticals are non-vaccine pharmacological or biological products used to prevent or treat patients exposed to either chemical warfare agents (CWA) or biological warfare agents (BWA).